TECH Quick Ratio Analysis

With a quick ratio of 2.77x, Bio-Techne holds $2.77 in highly liquid assets—like cash and receivables—for every $1 of short-term obligations, indicating strong ability to cover near-term bills without selling inventory.

This sits well above the Healthcare sector median of 1.12x, placing the company at the 83rd percentile among peers, meaning most comparable firms have thinner liquidity cushions. The trend is N/A because year-over-year change is N/A, quarter-over-quarter change is N/A, and no historical values beyond the current 2.77x are available, so no directional pattern can be assessed. The combination of an exceptionally high liquidity level with an unknown trend reduces immediate balance-sheet risk but leaves uncertainty about whether this buffer is growing or shrinking. This metric supports the overall NEUTRAL verdict because strong liquidity alone does not signal undervaluation or growth, while the lack of trend data prevents any bullish or bearish tilt.

Frequently Asked Questions

Closest Sector Peers